J Mauricio Sánchez1, Margaret A Yanics2, Patricia Wilson2, Amit Doshi2, Thomas Kurian2, Stephen Pieper3. 1. Division of Cardiac Electrophysiology, The Heart Health Center, 450 North New Ballas Road West Wing 270, Saint Louis, MO, 63141, USA. Jsanchez@hearthealthcenter.com. 2. Division of Cardiac Electrophysiology, Mercy Heart and Vascular, Saint Louis, MO, 63141, USA. 3. Division of Cardiac Electrophysiology, The Heart Health Center, 450 North New Ballas Road West Wing 270, Saint Louis, MO, 63141, USA.
Abstract
BACKGROUND: Ablation procedures for arrhythmias have increased in frequency and complexity over the last decade. Improvements in technology have allowed for less reliance on fluoroscopy to guide these procedures. Ablation without fluoroscopy has been reported in small cohorts. We report a single center experience of fluoroless ablation after adoption of this technique for all endovascular ablations. METHODS: This retrospective study evaluated 107 consecutive patients who underwent a catheter ablation procedure for an atrial or ventricular arrhythmias after adoption of a completely fluoroless technique. No fluoroscopy was used in any case. A mapping system was utilized in all cases. Intracardiac echocardiography (ICE) catheters were utilized in 75 of the ablation cases (70.4%). Of the 107 patients who underwent EP study, three patients did not undergo ablation as they were non-inducible for SVT. Of the remaining 104 patients, 56 patients (53.8%) underwent ablation for atrial fibrillation, 23 patients (22.1%) for SVT, 10 patients (9.6%) for lone atrial flutter, and 16 patients (15.4%) for a ventricular arrhythmia including PVC, idiopathic VT or ventricular tachycardia. RESULTS: Catheters were able to be placed in 100% of patients without complication. Time to placement in the coronary sinus was 2.1 min ± 1.4 min. Mean transseptal time was 3.54 min ± 3 min. Mean procedure time for all ablations was 2 h 6 min ± 50 min. There were no complications in the series of patients. CONCLUSIONS: Fluoroless ablation is feasible and safe with acceptable procedure times. Adoption of this technique is encouraged in order to eliminate unnecessary risk of fluoroscopy.
BACKGROUND: Ablation procedures for arrhythmias have increased in frequency and complexity over the last decade. Improvements in technology have allowed for less reliance on fluoroscopy to guide these procedures. Ablation without fluoroscopy has been reported in small cohorts. We report a single center experience of fluoroless ablation after adoption of this technique for all endovascular ablations. METHODS: This retrospective study evaluated 107 consecutive patients who underwent a catheter ablation procedure for an atrial or ventricular arrhythmias after adoption of a completely fluoroless technique. No fluoroscopy was used in any case. A mapping system was utilized in all cases. Intracardiac echocardiography (ICE) catheters were utilized in 75 of the ablation cases (70.4%). Of the 107 patients who underwent EP study, three patients did not undergo ablation as they were non-inducible for SVT. Of the remaining 104 patients, 56 patients (53.8%) underwent ablation for atrial fibrillation, 23 patients (22.1%) for SVT, 10 patients (9.6%) for lone atrial flutter, and 16 patients (15.4%) for a ventricular arrhythmia including PVC, idiopathic VT or ventricular tachycardia. RESULTS: Catheters were able to be placed in 100% of patients without complication. Time to placement in the coronary sinus was 2.1 min ± 1.4 min. Mean transseptal time was 3.54 min ± 3 min. Mean procedure time for all ablations was 2 h 6 min ± 50 min. There were no complications in the series of patients. CONCLUSIONS: Fluoroless ablation is feasible and safe with acceptable procedure times. Adoption of this technique is encouraged in order to eliminate unnecessary risk of fluoroscopy.
Authors: M C Limacher; P S Douglas; G Germano; W K Laskey; B D Lindsay; M H McKetty; M E Moore; J K Park; F M Prigent; M N Walsh Journal: J Am Coll Cardiol Date: 1998-03-15 Impact factor: 24.094
Authors: J Damilakis; N Theocharopoulos; K Perisinakis; E Manios; P Dimitriou; P Vardas; N Gourtsoyiannis Journal: Circulation Date: 2001-08-21 Impact factor: 29.690
Authors: John D Ferguson; Adam Helms; J Michael Mangrum; Srijoy Mahapatra; Pamela Mason; Ken Bilchick; George McDaniel; David Wiggins; John P DiMarco Journal: Circ Arrhythm Electrophysiol Date: 2009-12
Authors: Federica Troisi; Pietro Guida; Federico Quadrini; Antonio Di Monaco; Nicola Vitulano; Rosa Caruso; Rocco Orfino; Giacomo Cecere; Matteo Anselmino; Massimo Grimaldi Journal: Front Cardiovasc Med Date: 2022-04-28
Authors: Grzegorz Karkowski; Marcin Kuniewicz; Edward Koźluk; Tomasz Chyży; Andrzej Ząbek; Michał Dusza; Jacek Lelakowski Journal: Postepy Kardiol Interwencyjnej Date: 2020-10-02 Impact factor: 1.426